Wockhardt Ltd — Capital/Financing Update 2021

Sep 3, 2021

==> picture [167 x 46] intentionally omitted <==

3[rd] September, 2021

BSE LimitedCorporate Relations DepartmentP J Towers,Dalal StreetMumbai - 400 001Scrip Code: 532300		National Stock Exchange of India LimitedListing DepartmentExchange PlazaBandra Kurla Complex, Bandra (E),Mumbai - 400 051NSE Symbol– WOCKPHARMA

Dear Sir/ Madam,

Sub: Credit Rating

Pursuant to regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that CARE Ratings Limited (CARE Ratings) has assigned CARE BBB-; Stable (Triple B Minus; Outlook: Stable) for the Non-Convertible Debentures aggregating upto Rs. 50 crores proposed to be issued by the Company and also reaffirmed the Company’s Ratings for:

1. Long-Term Bank Facilities (Fund Based) of Rs. 700 Crore as “CARE BBB-; Stable” ;

2. Short Term Bank Facilities (Non-Fund Based) of Rs. 307.80 Crore as “CARE A3” ; and

3. Non-Convertible Debenture of Rs. 200 crore as “CARE BBB-; Stable”

The rating was given, inter alia, after factoring in considerable reduction in term debt, the Company’s tie up with global players for manufacturing and supply of vaccines and respiratory drugs, established track record of company in global pharmaceutical industry as well as experienced and resourceful promoters, strong and diversified product portfolio across multiple therapeutic segments with established marketing network and global presence as well as accredited manufacturing facilities with R&D focused approach.

Thanking you,

For Wockhardt Limited

==> picture [116 x 52] intentionally omitted <==

Debashis Dey Company Secretary

==> picture [106 x 46] intentionally omitted <==

==> picture [482 x 30] intentionally omitted <==